Literature DB >> 33408718

Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease.

Lindsey E Fox1, Marissa C Locke1, Deborah J Lenschow1,2.   

Abstract

Type I interferons (IFNs) are critical effector cytokines of the immune system and were originally known for their important role in protecting against viral infections; however, they have more recently been shown to play protective or detrimental roles in many disease states. Type I IFNs consist of IFNα, IFNβ, IFNϵ, IFNκ, IFNω, and a few others, and they all signal through a shared receptor to exert a wide range of biological activities, including antiviral, antiproliferative, proapoptotic, and immunomodulatory effects. Though the individual type I IFN subtypes possess overlapping functions, there is growing appreciation that they also have unique properties. In this review, we summarize some of the mechanisms underlying differential expression of and signaling by type I IFNs, and we discuss examples of differential functions of IFNα and IFNβ in models of infectious disease, cancer, and autoimmunity.
Copyright © 2020 Fox, Locke and Lenschow.

Entities:  

Keywords:  IFNα subtypes; IFNβ; autoimmunity; cancer; infection; type I interferons

Mesh:

Substances:

Year:  2020        PMID: 33408718      PMCID: PMC7779635          DOI: 10.3389/fimmu.2020.606874

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  347 in total

Review 1.  Malaria.

Authors:  Margaret A Phillips; Jeremy N Burrows; Christine Manyando; Rob Hooft van Huijsduijnen; Wesley C Van Voorhis; Timothy N C Wells
Journal:  Nat Rev Dis Primers       Date:  2017-08-03       Impact factor: 52.329

2.  Interferon-alpha: a therapeutic target in systemic lupus erythematosus.

Authors:  Mary K Crow
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

3.  Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Authors:  Antonella Sistigu; Takahiro Yamazaki; Erika Vacchelli; Kariman Chaba; David P Enot; Julien Adam; Ilio Vitale; Aicha Goubar; Elisa E Baracco; Catarina Remédios; Laetitia Fend; Dalil Hannani; Laetitia Aymeric; Yuting Ma; Mireia Niso-Santano; Oliver Kepp; Joachim L Schultze; Thomas Tüting; Filippo Belardelli; Laura Bracci; Valentina La Sorsa; Giovanna Ziccheddu; Paola Sestili; Francesca Urbani; Mauro Delorenzi; Magali Lacroix-Triki; Virginie Quidville; Rosa Conforti; Jean-Philippe Spano; Lajos Pusztai; Vichnou Poirier-Colame; Suzette Delaloge; Frederique Penault-Llorca; Sylvain Ladoire; Laurent Arnould; Joanna Cyrta; Marie-Charlotte Dessoliers; Alexander Eggermont; Marco E Bianchi; Mikael Pittet; Camilla Engblom; Christina Pfirschke; Xavier Préville; Gilles Uzè; Robert D Schreiber; Melvyn T Chow; Mark J Smyth; Enrico Proietti; Fabrice André; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

4.  Different antiviral effects of IFNα and IFNβ in an HBV mouse model.

Authors:  Yun Zhou; Sheng Li; Zongsheng Tang; Chunli Xu; Shunmei Huang; Jun Wu; Ulf Dittmer; Julia Dickow; Kathrin Sutter; Mengji Lu; Dongliang Yang; Jingjiao Song
Journal:  Immunobiology       Date:  2016-11-08       Impact factor: 3.144

5.  Cloning and characterization of a novel feline IFN-omega.

Authors:  Li-Min Yang; Qing-Hua Xue; Lei Sun; Yi-Ping Zhu; Wen-Jun Liu
Journal:  J Interferon Cytokine Res       Date:  2007-02       Impact factor: 2.607

6.  IFNAR1 controls progression to cerebral malaria in children and CD8+ T cell brain pathology in Plasmodium berghei-infected mice.

Authors:  Elizabeth Ann Ball; Maria Rosário Sambo; Madalena Martins; Maria Jesus Trovoada; Carla Benchimol; João Costa; Lígia Antunes Gonçalves; António Coutinho; Carlos Penha-Gonçalves
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

7.  Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection.

Authors:  Stephane Daffis; Melanie A Samuel; Mehul S Suthar; Brian C Keller; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

8.  Effects of type I interferons on Friend retrovirus infection.

Authors:  Nicole Gerlach; Simone Schimmer; Siegfried Weiss; Ulrich Kalinke; Ulf Dittmer
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Characterization of the type I interferon locus and identification of novel genes.

Authors:  Matthew P Hardy; Catherine M Owczarek; Lars S Jermiin; Mikael Ejdebäck; Paul J Hertzog
Journal:  Genomics       Date:  2004-08       Impact factor: 5.736

10.  Route of Infection Determines the Impact of Type I Interferons on Innate Immunity to Listeria monocytogenes.

Authors:  Elisabeth Kernbauer; Verena Maier; Isabella Rauch; Mathias Müller; Thomas Decker
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

View more
  4 in total

1.  Alum-anchored intratumoral retention improves the tolerability and antitumor efficacy of type I interferon therapies.

Authors:  Emi A Lutz; Yash Agarwal; Noor Momin; Sarah C Cowles; Joseph R Palmeri; Ellen Duong; Vladlena Hornet; Allison Sheen; Brianna M Lax; Adrienne M Rothschilds; Darrell J Irvine; Stefani Spranger; K Dane Wittrup
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

2.  Interferon Alpha, but Not Interferon Beta, Acts Early To Control Chronic Chikungunya Virus Pathogenesis.

Authors:  Marissa C Locke; Lindsey E Fox; Bria F Dunlap; Alissa R Young; Kristen Monte; Deborah J Lenschow
Journal:  J Virol       Date:  2021-10-20       Impact factor: 6.549

3.  A novel phosphoproteomic landscape evoked in response to type I interferon in the brain and in glial cells.

Authors:  Barney Viengkhou; Melanie Y White; Stuart J Cordwell; Iain L Campbell; Markus J Hofer
Journal:  J Neuroinflammation       Date:  2021-10-16       Impact factor: 8.322

4.  Comparison by Age of the Local Interferon Response to SARS-CoV-2 Suggests a Role for IFN-ε and -ω.

Authors:  Alessandra Pierangeli; Massimo Gentile; Giuseppe Oliveto; Federica Frasca; Leonardo Sorrentino; Luigi Matera; Raffaella Nenna; Agnese Viscido; Matteo Fracella; Laura Petrarca; Gabriella D'Ettorre; Giancarlo Ceccarelli; Fabio Midulla; Guido Antonelli; Carolina Scagnolari
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.